Story perspectives

Lawmakers Back Louisiana's Lawsuit Against FDA on Mifepristone

2/26/2026

Summary

Story summary

Sixty lawmakers filed an amicus brief supporting Louisiana's lawsuit against the U.S. Food and Drug Administration.
The lawsuit challenges the removal of the in-person dispensing requirement for mifepristone, citing the federal Comstock Act.
Louisiana Attorney General Liz Murrill says the changes undermine state laws and endanger women.
The brief argues the FDA's actions lack safety evidence and violate separation of powers.
The case is before the Western District of Louisiana.

1 of 1

Story summary

Sixty lawmakers filed an amicus brief supporting Louisiana's lawsuit against the U.S. Food and Drug Administration.
The lawsuit challenges the removal of the in-person dispensing requirement for mifepristone, citing the federal Comstock Act.
Louisiana Attorney General Liz Murrill says the changes undermine state laws and endanger women.
The brief argues the FDA's actions lack safety evidence and violate separation of powers.
The case is before the Western District of Louisiana.